Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology

Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership Technicals

Ticker	Company	Exchange	Industry	Market Cap	Price	1d %	EBITDA	P/E	D/E
CADL	CANDEL THERAPEUTICS INC	NASDAQ	Biotechnology	$188.70M	$6.43	6.28%	-$34.14M	-4.91x	2.23
CTCX	CARMELL CORP	NASDAQ	Biotechnology	$40.22M	$2.09	3.98%	-$14.47M	-1.43x	1.58
BIVI	BIOVIE INC	NASDAQ	Biotechnology	$19.50M	$0.49	-3.17%	-$39.04M	-0.42x	1.87
GRI	GRI BIO INC	NASDAQ	Biotechnology	$1.37M	$0.43	-1.60%	-$10.95M	-0.02x	10.41
VERU	VERU INC	NASDAQ	Biotechnology	$177.12M	$1.21	-8.33%	-$62.11M	-1.61x	0.56
SANA	SANA BIOTECHNOLOGY INC	NASDAQ	Biotechnology	$1.87B	$8.50	-0.93%	-$245.43M	-5.82x	0.97
BPTH	BIO-PATH HOLDINGS INC	NASDAQ	Biotechnology	$1.79M	$2.64	5.82%	-$15.90M	-0.08x	6.30
NCNA	NUCANA PLC	NASDAQ	Biotechnology	$8.06M	$3.81	-0.78%	-$40.33M	-0.22x	0.87
VINC	VINCERX PHARMA INC	NASDAQ	Biotechnology	$19.21M	$0.90	-3.55%	-$39.24M	-0.47x	0.62
PRME	PRIME MEDICINE INC	NASDAQ	Biotechnology	$515.74M	$4.30	-8.51%	-$180.97M	-1.97x	0.46
WINT	WINDTREE THERAPEUTICS INC	NASDAQ	Biotechnology	$2.59M	$5.07	-1.65%	-$19.75M	-0.05x	8.56
RENB	RENOVARO INC	NASDAQ	Biotechnology	$244.24M	$1.70	-13.71%	-$40.26M	-2.43x	0.33
EFTR	EFFECTOR THERAPEUTICS INC	NASDAQ	Biotechnology	$6.67M	$1.81	-2.16%	-$32.78M	-0.11x	-4.55
ABVC	ABVC BIOPHARMA INC	NASDAQ	Biotechnology	$16.79M	$1.59	7.43%	-$7.74M	-0.65x	0.76
SER	SERINA THERAPEUTICS INC	NYSEMKT	Biotechnology	$22.98M	$9.19	-8.09%	-$9.77M	-0.67x	1.21
APTO	APTOSE BIOSCIENCES INC	NASDAQ	Biotechnology	$18.23M	$1.16	-4.92%	-$50.74M	-0.15x	-5.48
ERNA	ETERNA THERAPEUTICS INC	NASDAQ	Biotechnology	$9.39M	$1.74	-0.23%	-$19.93M	-0.43x	21.00
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	NASDAQ	Biotechnology	$351.52M	$33.50	-5.74%	-$41.04M	-3.25x	-5.10
KA	KINETA INC	NASDAQ	Biotechnology	$7.02M	$0.64	3.23%	-$13.01M	-0.50x	2.50
AEON	AEON BIOPHARMA INC	NYSEMKT	Biotechnology	$160.60M	$4.25	5.99%	$24.09M	6.54x	-1.05
ARMP	ARMATA PHARMACEUTICALS INC	NYSEMKT	Biotechnology	$91.49M	$2.53	1.24%	-$65.45M	-1.33x	-4.07
CSBR	CHAMPIONS ONCOLOGY INC	NASDAQ	Biotechnology	$68.78M	$5.06	0.60%	-$7.67M	-7.03x	-14.02
ASLN	ASLAN PHARMACEUTICALS LTD	NASDAQ	Biotechnology	$7.88M	$0.45	-4.68%	-$39.41M	-0.16x	-2.85
NVAX	NOVAVAX INC	NASDAQ	Biotechnology	$552.81M	$3.95	-4.82%	-$487.39M	-0.73x	-3.51
JAGX	JAGUAR HEALTH INC	NASDAQ	Biotechnology	$46.96M	$0.17	0.00%	-$32.53M	-0.09x	9.25
PSTV	PLUS THERAPEUTICS INC	NASDAQ	Biotechnology	$7.12M	$1.67	4.06%	-$12.18M	-0.39x	-9.45
ATRA	ATARA BIOTHERAPEUTICS INC	NASDAQ	Biotechnology	$83.55M	$0.70	-2.10%	-$254.20M	-0.27x	-2.67
YS	YS BIOPHARMA CO LTD	NASDAQ	Biotechnology	$73.98M	$0.80	-1.85%	N/A	N/A	2.18
IBIO	IBIO INC	NYSEMKT	Biotechnology	$5.99M	$1.72	-9.47%	-$25.95M	-0.11x	2.70
HCWB	HCW BIOLOGICS INC	NASDAQ	Biotechnology	$55.22M	$1.46	-2.67%	-$23.58M	-2.09x	1.12
HUMA	HUMACYTE INC	NASDAQ	Biotechnology	$464.43M	$3.90	2.09%	-$96.41M	-3.64x	8.47
DRMA	DERMATA THERAPEUTICS INC	NASDAQ	Biotechnology	$2.26M	$0.34	-4.76%	-$7.79M	-0.13x	0.26
ICCC	IMMUCELL CORP	NASDAQ	Biotechnology	$39.53M	$5.10	1.19%	-$3.05M	-6.80x	0.75
MAIA	MAIA BIOTECHNOLOGY INC	NYSEMKT	Biotechnology	$53.61M	$2.68	-0.37%	-$19.77M	-1.80x	14.85
GRTX	GALERA THERAPEUTICS INC	NASDAQ	Biotechnology	$11.26M	$0.21	13.11%	-$47.41M	-0.16x	-1.20
ZVSA	ZYVERSA THERAPEUTICS INC	NASDAQ	Biotechnology	$4.62M	$0.61	-0.33%	-$107.74M	-0.01x	1.00
ENGN	ENGENE HOLDINGS INC	NASDAQ	Biotechnology	$641.52M	$14.72	-0.20%	N/A	N/A	0.50
EPRX	EUPRAXIA PHARMACEUTICALS INC	NASDAQ	Biotechnology	N/A	$2.85	-2.40%	-$27.60M	-2.44x	8.74
ELTX	ELICIO THERAPEUTICS INC	NASDAQ	Biotechnology	$93.14M	$9.10	-1.62%	-$32.97M	-1.31x	1.39
ACXP	ACURX PHARMACEUTICALS INC	NASDAQ	Biotechnology	$31.83M	$2.02	-0.49%	-$14.58M	-1.76x	0.65
RANI	RANI THERAPEUTICS HOLDINGS INC	NASDAQ	Biotechnology	$329.03M	$6.56	-6.15%	-$27.02M	-4.93x	2.52
MBIO	MUSTANG BIO INC	NASDAQ	Biotechnology	$3.64M	$0.35	0.00%	-$45.27M	-0.06x	143.24
ENSC	ENSYSCE BIOSCIENCES INC	NASDAQ	Biotechnology	$4.01M	$0.55	-2.15%	-$10.26M	-0.12x	-10.41
AKTX	AKARI THERAPEUTICS PLC	NASDAQ	Biotechnology	$18.86M	$1.19	0.00%	-$10.00M	N/A	-20.02
CLRB	CELLECTAR BIOSCIENCES INC	NASDAQ	Biotechnology	$97.43M	$3.02	-1.31%	-$37.79M	-0.97x	-9.91
CING	CINGULATE INC	NASDAQ	Biotechnology	$4.21M	$0.84	-3.45%	-$22.18M	-0.03x	-1.51
CNSP	CNS PHARMACEUTICALS INC	NASDAQ	Biotechnology	$2.17M	$0.20	-4.67%	-$18.83M	-0.04x	-1.38
ACHV	ACHIEVE LIFE SCIENCES INC	NASDAQ	Biotechnology	$156.70M	$4.58	0.77%	-$26.73M	-3.05x	-14.38
CHRO	CHROMOCELL THERAPEUTICS CORP	NYSEMKT	Biotechnology	$8.82M	$1.50	-4.46%	-$6.86M	-0.26x	-1.02
BPTS	BIOPHYTIS SA	NASDAQ	Biotechnology	$0.00	$8.22	-15.28%	-$15.86M	-0.06x	-4.11
SKYE	SKYE BIOSCIENCE INC	NASDAQ	Biotechnology	N/A	$12.85	0.00%	-$36.61M	-2.39x	-6.60
BCLI	BRAINSTORM CELL THERAPEUTICS INC	NASDAQ	Biotechnology	$36.36M	$0.53	-2.39%	-$16.48M	-1.33x	-1.87
NRSN	NEUROSENSE THERAPEUTICS LTD	NASDAQ	Biotechnology	$19.38M	$1.26	-5.97%	-$8.97M	-1.52x	-2.70
ALZN	ALZAMEND NEURO INC	NASDAQ	Biotechnology	$4.81M	$0.70	-1.27%	-$12.35M	-0.37x	-1.07
OTLK	OUTLOOK THERAPEUTICS INC	NASDAQ	Biotechnology	$106.58M	$8.19	-0.12%	-$52.51M	-2.05x	-1.89
UNCY	UNICYCIVE THERAPEUTICS INC	NASDAQ	Biotechnology	$33.71M	$0.97	-6.73%	-$30.18M	-0.76x	-4.73
PTN	PALATIN TECHNOLOGIES INC	NYSEMKT	Biotechnology	$27.76M	$1.72	-0.58%	-$31.25M	-0.66x	-2.15
QLGN	QUALIGEN THERAPEUTICS INC	NASDAQ	Biotechnology	$1.87M	$0.30	-3.88%	-$11.89M	-0.11x	-1.97
ALLR	ALLARITY THERAPEUTICS INC	NASDAQ	Biotechnology	$441.79k	$1.43	4.38%	-$11.28M	-0.01x	-5.31
SLS	SELLAS LIFE SCIENCES GROUP INC	NASDAQ	Biotechnology	$85.53M	$1.52	-1.30%	-$36.85M	-1.13x	-1.78
VCNX	VACCINEX INC	NASDAQ	Biotechnology	$7.30M	$5.93	18.50%	-$20.13M	-0.14x	-2.57
NRXP	NRX PHARMACEUTICALS INC	NASDAQ	Biotechnology	$30.05M	$3.14	0.64%	-$30.03M	-0.79x	-1.62
IVA	INVENTIVA SA	NASDAQ	Biotechnology	$164.69M	$3.16	-2.47%	-$109.06M	-1.20x	-3.17
VTVT	VTV THERAPEUTICS INC	NASDAQ	Biotechnology	$77.57M	$25.77	1.06%	-$20.15M	-2.65x	-1.20
ATNF	180 LIFE SCIENCES CORP	NASDAQ	Biotechnology	$1.51M	$1.77	-2.80%	-$22.13M	-0.03x	-42.18
SCNI	SCINAI IMMUNOTHERAPEUTICS LTD	NASDAQ	Biotechnology	$1.96M	$0.45	-4.66%	N/A	-0.09x	-7.90
RVPH	REVIVA PHARMACEUTICALS HOLDINGS INC	NASDAQ	Biotechnology	$83.20M	$2.98	-1.32%	-$39.24M	-1.81x	3.14
ONCO	ONCONETIX INC	NASDAQ	Biotechnology	$2.68M	$0.12	-1.64%	-$36.71M	-0.05x	-3.91
BCTX	BRIACELL THERAPEUTICS CORP	NASDAQ	Biotechnology	$35.80M	$2.24	2.28%	-$17.21M	-2.80x	-2.55
KTRA	KINTARA THERAPEUTICS INC	NASDAQ	Biotechnology	$6.17M	$0.16	15.33%	-$10.58M	-0.03x	-12.49
ANVS	ANNOVIS BIO INC	NYSE	Biotechnology	$149.75M	$13.60	6.75%	-$56.20M	-2.18x	-2.32
OKYO	OKYO PHARMA LTD	NASDAQ	Biotechnology	$36.98M	$1.45	2.62%	-$13.18M	-2.37x	-3.53
GALT	GALECTIN THERAPEUTICS INC	NASDAQ	Biotechnology	$216.66M	$3.50	6.38%	-$41.86M	-4.73x	-1.43
CDT	CONDUIT PHARMACEUTICALS INC	NASDAQ	Biotechnology	$228.87M	$3.10	-2.52%	-$324.00k	-310.00x	-16.81
RNXT	RENOVORX INC	NASDAQ	Biotechnology	$20.41M	$1.21	-0.25%	-$10.12M	-1.22x	-1.49
INKT	MINK THERAPEUTICS INC	NASDAQ	Biotechnology	$30.22M	$0.87	-2.02%	-$22.25M	-1.34x	-1.25
NLSP	NLS PHARMACEUTICS LTD	NASDAQ	Biotechnology	$4.71M	$0.13	5.60%	-$15.36M	-0.26x	-1.53
ICU	SEASTAR MEDICAL HOLDING CORP	NASDAQ	Biotechnology	$36.43M	$0.48	-4.92%	-$25.15M	-0.40x	-1.25
CLDI	CALIDI BIOTHERAPEUTICS INC	NYSEMKT	Biotechnology	$5.69M	$0.16	1.27%	-$26.88M	-0.09x	-2.22
NKGN	NKGEN BIOTECH INC	NASDAQ	Biotechnology	$45.16M	$1.98	15.79%	-$80.64M	-0.37x	-1.28
PBM	PSYENCE BIOMEDICAL LTD	NASDAQ	Biotechnology	$11.25M	$0.84	5.26%	$1.52M	-84.00x	-1.79
OCEA	OCEAN BIOMEDICAL INC	NASDAQ	Biotechnology	$42.86M	$1.26	-11.31%	-$97.33M	-0.32x	-1.01
TVGN	TEVOGEN BIO HOLDINGS INC	NASDAQ	Biotechnology	$130.26M	$0.85	-43.33%	-$78.35M	-0.26x	-1.07

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the top biotech stock with a Zen Score of 75, which is 52 points higher than the biotech industry average of 23. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -30.41% over the past year, underperforming other biotech stocks by -7 percentage points.

Incyte has an average 1 year price target of $74.69, an upside of 45.94% from Incyte's current stock price of $51.18.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 23.08% have issued a Strong Buy rating, 23.08% have issued a Buy, 53.85% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best biotech stock with a Zen Score of 70, which is 47 points higher than the biotech industry average of 23. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -8.91% over the past year, overperforming other biotech stocks by 15 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $37.33, an upside of 29.05% from Harmony Biosciences Holdings's current stock price of $28.93.

Harmony Biosciences Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 16.67% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Voyager Therapeutics (NASDAQ:VYGR)

Voyager Therapeutics (NASDAQ:VYGR) is the third best biotech stock with a Zen Score of 66, which is 43 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Voyager Therapeutics has seen its stock lose -1.33% over the past year, overperforming other biotech stocks by 22 percentage points.

Voyager Therapeutics has an average 1 year price target of $20.50, an upside of 176.28% from Voyager Therapeutics's current stock price of $7.42.

Voyager Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Voyager Therapeutics, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Carisma Therapeutics (NASDAQ:CARM)

Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of N/A, which is N/A percentage points lower than the biotech industry average of 14.87%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 56.45%, which is 42 percentage points higher than the biotech industry average of 14.87%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk A S (NYSE:NVO)

Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.09%, which is -14 percentage points lower than the biotech industry average of 14.87%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% eight times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 38.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -1.43% in the last day, and down -0.98% over the last week. Acrivon Therapeutics was the among the top losers in the biotechnology industry, dropping -10.84% yesterday.

Acrivon Therapeutics shares are trading higher after the company reported initial clinical data for ACR-368 and pipeline program progress today at a corporate R&D event.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 100, which is 86 points higher than the biotech industry average of 14. It passed 7 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -21.04% in the past year. It has overperformed other stocks in the biotech industry by 3 percentage points.

2. Voyager Therapeutics (NASDAQ:VYGR)

Voyager Therapeutics (NASDAQ:VYGR) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Voyager Therapeutics has a valuation score of 100, which is 86 points higher than the biotech industry average of 14. It passed 7 out of 7 valuation due diligence checks.

Voyager Therapeutics's stock has dropped -1.33% in the past year. It has overperformed other stocks in the biotech industry by 22 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -30.41% in the past year. It has underperformed other stocks in the biotech industry by -7 percentage points.

Are biotech stocks a good buy now?

49.03% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 94.43% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 15.41x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.